After Hours: 1.19 -0.03 -2.46%

Calidi Biotherapeutics Inc (CLDI)

Overview News Price History Discussions Forecast

Calidi Biotherapeutics Inc Stock (CLDI) Latest News

Calidi Biotherapeutics Inc (CLDI)

Calidi Biotherapeutics Inc Stock (CLDI) Latest News

Taking on analysts’ expectations and winning: Calidi Biotherapeutics Inc (CLDI) - SETE News

CLDI’s 2023 Market Dance: Up 13.04% – Time to Invest? - The InvestChronicle

A review of CLDI’s current quarter earnings predictions - US Post News

What Recent Market Trends Mean for Calidi Biotherapeutics Inc’s (CLDI) Stock - The News Heater

Calidi Biotherapeutics expands stock offering capacity - Investing.com India

Calidi Biotherapeutics expands stock offering capacity By Investing.com - Investing.com South Africa

Market Recap: Calidi Biotherapeutics Inc (CLDI)’s Positive Momentum, Closing at 1.32 - The Dwinnex

For Calidi Biotherapeutics Inc [CLDI], Analyst sees a rise to $11. What next? - The DBT News

Calidi Biotherapeutics Inc Inc. (CLDI) Price Performance: A Fundamental Analysis Perspective - The InvestChronicle

Get in on Calidi Biotherapeutics Inc’s (CLDI) buy-in window today! - SETE News

Taking a Closer Look At Calidi Biotherapeutics Inc (CLDI) Following Its Recent Trade - Knox Daily

CLDI’s price-to-sales ratio: A comparative analysis with its peers - US Post News

CLDI Stock Plummets to 52-Week Low at $0.6 Amid Market Turbulence - Investing.com Australia

Calidi Biotherapeutics Bolsters Cash Balance and Terminates Standby Equity Purchase AgreementSAN DIEGO, January 28, 2025 – Calidi Biotherapeutics Inc. (NYSE American: CLDI) recently disclosed the ending cash balance amounting to approximately $ - Defense World

Join Calidi Biotherapeutics' Exclusive Live Investor Webinar and Q&A Session on February 5 - The Manila Times

Join Calidi Biotherapeutics’ Exclusive Live Investor Webinar and Q&A Session on February 5 - GlobeNewswire

Inside Calidi's Game-Changing Cancer Treatment Pipeline: Top Execs Reveal Next-Gen Therapies - StockTitan

CLDICalidi Biotherapeutics, Inc. Latest Stock News & Market Updates - StockTitan

Calidi Biotherapeutics Ends SEPA After Successful Fundraising - TipRanks

Calidi Biotherapeutics Announces Bolstered Cash Balance and Termination of its Standby Equity Purchase Agreement - GlobeNewswire

Cancer Biotech Raises $18.8M War Chest to Fast-Track Revolutionary Brain Cancer Treatment - StockTitan

Why Calidi Biotherapeutics Inc (AMEX: CLDI) Is A Great Stock Pick For Momentum Investors - Stocks Register

Calidi Biotherapeutics and Gorilla Technology Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - ACCESS Newswire

CLDI stock touches 52-week low at $0.73 amid market challenges - Investing.com Australia

The Business Case For Buying Calidi Biotherapeutics Inc (AMEX: CLDI) Stock Now - Stocks Register

Calidi Biotherapeutics Announces Presentation of New Data - GlobeNewswire

Calidi Biotherapeutics to Present Breakthrough Cancer Treatment Platform at AACR 2025 Meeting - StockTitan

Calidi Biotherapeutics announces reverse stock split adjustment - Investing.com

Calidi Biotherapeutics (NYSE American: CLDI) Prices $4.25 Million Public Offering - The Globe and Mail

Calidi Biotherapeutics Announces $4.25 Million Public Stock Offering - Defense World

Calidi Biotherapeutics Refiles Consolidated Financial Statements After Reverse Stock Split - Defense World

Calidi Biotherapeutics Announces Closing of $4.25 Million Public Offering of Common Stock - The Bakersfield Californian

Calidi Biotherapeutics Raises $4.25M Through Public Offering of Common Stock at $0.85 Per Share - StockTitan

Why Calidi Biotherapeutics (CLDI) Stock Is Down 30% - Benzinga

Calidi Biotherapeutics slumps 29%, prices $4.25M stock offering - MSN

Calidi Biotherapeutics Announces Public Stock Offering Deal - TipRanks

Calidi Biotherapeutics Announces Pricing of $4.25 Million Public Offering of Common Stock - The Bakersfield Californian

Calidi Biotherapeutics Raises $4.25M Through Public Offering to Advance Cancer Immunotherapy Platform - StockTitan

12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga

Calidi Biotherapeutics (NYSE:CLDI) Stock Price Down 8.2% – Should You Sell? - Defense World

Calidi Biotherapeutics Announces Proposed Public Offering - The Manila Times

Calidi Biotherapeutics Announces Common Stock Public Offering to Advance Immunotherapy Pipeline - StockTitan

Reviewing Calidi Biotherapeutics (NYSE:CLDI) & iTeos Therapeutics (NASDAQ:ITOS) - Defense World

Comparing Calidi Biotherapeutics (NYSE:CLDI) & Immatics (NASDAQ:IMTX) - Defense World

Calidi Biotherapeutics CEO Allan Camaisa sells $16,200 in stock - Investing.com India

Calidi Biotherapeutics prices $7.5M secondary offering - MSN

Calidi Biotherapeutics Inc (CLDI-A) QuotePress Release - The Globe and Mail

Similar to CLDI